企業リスク管理における労働安全と健康の統合:構造的評価
1Institute of Pure and Applied Sciences, Marmara University, Istanbul, Türkiye.
Frontiers in public health
|August 20, 2025
まとめ
企業リスク管理 (ERM) に労働安全衛生 (OHS) リスクを統合することは可能である. 特に内部監査を通じてOHSをERMに整合させることで,リスクガバナンスと組織の回復力を高めます.
科学分野:
- リスク管理
- 労働衛生と安全
- 内部監査
背景:
- 企業リスク管理 (ERM) と労働安全衛生 (OHS) のシステムは,共通の目標にもかかわらず,しばしば独立して機能します.
- この研究は,組織的なリスク管理に統一されたアプローチの必要性を扱っています.
研究 の 目的:
- ERMの枠組みにOHSリスクの統合を調査する.
- 特に内部監査を通じて,OHSの実践とERMの戦略を整合させることで,リスク管理が改善される方法を検討する.
主な方法:
- 国内法,ISO 31000,ISO 45001の定性文書分析と学術研究について
- 評価は,ERM,内部監査 (IA),およびOHSにおける構造的類似性,手続きの交差点,および機能的な役割に焦点を当てた.
主要な成果:
- リスクの特定,予防,モニタリングにおけるERMとOHSの重要な収束が確認されました.
- 内部監査とOHSの専門家が,コンプライアンス,ドキュメンテーション,および危険性評価に関する責任を重複しています.
- これらのパラレルによって,OHSリスク管理をERMに統合する可能性を裏付けています.
結論:
- 企業レベルのリスクガバナンスには,OSHリスクをERMに統合することが不可欠です.
- この統合はリスク管理を合理化し,監査の効率を高め,組織の回復力を向上させます.
- OHS部門と内部監査システムの緊密な協力により,より安全な職場と戦略的なリスクの監視が促進されます.
関連する概念動画
01:21Types of Reports II: Incident or Occurrence Report
945
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
945
01:11Hazard Rate
184
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
184
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
173
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
173
01:12Relative Risk
334
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
334
01:22Design Consideration
318
Designing a structure involves a series of considerations, primarily the material's ultimate strength, calculated through tests that measure changes under increased force until the material reaches its breaking point or limit. The ultimate load, where the material breaks, is divided by its original cross-sectional area, resulting in the ultimate normal stress or strength. The ultimate shearing stress is another significant factor taken into account.
The factor of safety is another key...
The factor of safety is another key...
318
01:12Hazard Ratio
240
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
240